Chimera Investment (NYSE:CIM) Price Target Cut to $15.00 by Analysts at Keefe, Bruyette & Woods

Chimera Investment (NYSE:CIM - Get Free Report) had its price target lowered by stock analysts at Keefe, Bruyette & Woods from $16.50 to $15.00 in a report issued on Thursday,Benzinga reports. The brokerage presently has a "market perform" rating on the real estate investment trust's stock. Keefe, Bruyette & Woods' price target suggests a potential upside of 6.65% from the stock's previous close.

Several other research firms have also recently weighed in on CIM. Wall Street Zen upgraded shares of Chimera Investment from a "hold" rating to a "buy" rating in a report on Thursday, May 15th. UBS Group upgraded shares of Chimera Investment from a "neutral" rating to a "buy" rating and lifted their price target for the company from $11.50 to $15.00 in a report on Wednesday, May 14th. Finally, Royal Bank Of Canada upgraded shares of Chimera Investment to a "moderate buy" rating in a report on Friday, March 14th. Two investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat, Chimera Investment has an average rating of "Moderate Buy" and an average price target of $15.50.

Chimera Investment Trading Down 0.5%

Shares of NYSE CIM traded down $0.08 during mid-day trading on Thursday, hitting $14.07. The stock had a trading volume of 439,265 shares, compared to its average volume of 564,819. The company has a debt-to-equity ratio of 3.93, a quick ratio of 3.70 and a current ratio of 3.70. Chimera Investment has a 1 year low of $9.85 and a 1 year high of $16.89. The business has a 50 day moving average price of $13.56 and a two-hundred day moving average price of $13.44. The firm has a market cap of $1.14 billion, a P/E ratio of 9.38 and a beta of 1.74.

Chimera Investment (NYSE:CIM - Get Free Report) last issued its earnings results on Thursday, May 8th. The real estate investment trust reported $0.41 EPS for the quarter, topping the consensus estimate of $0.38 by $0.03. Chimera Investment had a net margin of 25.12% and a return on equity of 7.25%. The company had revenue of $69.22 million for the quarter, compared to the consensus estimate of $72.07 million. On average, equities analysts anticipate that Chimera Investment will post 1.57 EPS for the current fiscal year.

Institutional Trading of Chimera Investment

Hedge funds have recently modified their holdings of the business. Barclays PLC boosted its holdings in shares of Chimera Investment by 12.4% during the 4th quarter. Barclays PLC now owns 206,059 shares of the real estate investment trust's stock valued at $2,885,000 after buying an additional 22,764 shares in the last quarter. Prudential Financial Inc. boosted its holdings in shares of Chimera Investment by 79.0% during the 4th quarter. Prudential Financial Inc. now owns 56,659 shares of the real estate investment trust's stock valued at $793,000 after buying an additional 25,000 shares in the last quarter. Deutsche Bank AG boosted its holdings in shares of Chimera Investment by 47.6% during the 4th quarter. Deutsche Bank AG now owns 69,741 shares of the real estate investment trust's stock valued at $976,000 after buying an additional 22,476 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Chimera Investment by 84.7% during the 4th quarter. JPMorgan Chase & Co. now owns 309,935 shares of the real estate investment trust's stock valued at $4,339,000 after buying an additional 142,105 shares in the last quarter. Finally, Manning & Napier Advisors LLC boosted its stake in Chimera Investment by 50.0% in the 1st quarter. Manning & Napier Advisors LLC now owns 150,000 shares of the real estate investment trust's stock worth $1,924,000 after purchasing an additional 50,000 shares in the last quarter. Institutional investors own 48.44% of the company's stock.

Chimera Investment Company Profile

Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities.